Powder: -20°C for 3 years | In solvent: -80°C for 1 year
UB 165 fumarate is an agonist of the nAChR, a partial agonist of the α4β2 subtype, and a full agonist of the α3β2 subtype, with a Ki value of 0.27 nM for binding to [3H]-nicotine measured in rat brain.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 350.00 | |
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | UB 165 fumarate is an agonist of the nAChR, a partial agonist of the α4β2 subtype, and a full agonist of the α3β2 subtype, with a Ki value of 0.27 nM for binding to [3H]-nicotine measured in rat brain. |
Targets&IC50 | Nicotine (rat brain):ki:0.27 nM , Nicotine (rat brain):0.27 nM(ki) |
In vitro | UB-165 fumarate exhibits an EC50 value of 88 nM for stimulating [3H]-dopamine release from striatal synaptosomes.[1] |
Synonyms | UB-165 fumarate, UB165 fumarate |
Molecular Weight | 350.8 |
Formula | C17H19ClN2O4 |
CAS No. | 2454492-43-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
UB 165 fumarate 2454492-43-2 Neuroscience AChR UB165 Fumarate UB-165 fumarate UB165 fumarate UB-165 Fumarate UB 165 Fumarate inhibitor inhibit